Birdwatch Note Rating
2023-03-17 20:01:53 UTC - HELPFUL
Rated by Participant: CCC328C7A178EFC4AB919FD27F98EEA9BF503F6BB67655DBD67A0716C0E0EFC9
Participant Details
Original Note:
The puberty blocker Lupron was never approved for gender-affirming care: it was trialled and approved by the FDA for precocious puberty in 6-8 year old girls. There are currently no peer-reviewed long-term studies on the effects of blockers on sexual function and fertility. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020263s050lbl.pdf
All Note Details